Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors Versus Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma with First- or Lower-Order Portal Vein Tumor Thrombosis.
Jin-Xing ZhangYuan ChengJuan WeiWen-Long FanJin LiuChun-Gao ZhouSheng LiuHai-Bin ShiXiao-Yuan ChuWei-Liang ZhengQing-Quan ZuPublished in: Cardiovascular and interventional radiology (2024)
TACE-TKI-ICI therapy contributed to better tumor control, PFS and OS than TKI-ICI therapy in unresectable HCC patients with first- or lower-order PVTT.